An officer of Hims & Hers Health, Inc. filed a Form 144 notice on November 17, 2026, disclosing a proposed sale of 3,458 Class A shares on the New York Stock Exchange through Fidelity Brokerage Services LLC.
Key Highlights
- Proposed sale: Soleil Boughton, an officer of Hims & Hers Health, Inc., proposes to sell 3,458 Class A shares with an aggregate market value of $64,076.74.
- Acquisition date: The shares were acquired on November 15, 2026, through restricted stock vesting from the issuer, with compensation as the nature of payment.
- Approximate sale date: The filing lists November 17, 2026, as the approximate date of sale on the NYSE.
- 10b5-1 plan: The filing indicates a Rule 10b5-1 trading plan was adopted on May 21, 2026.
- Shares outstanding: According to the filing, 226,034,799 Class A shares were outstanding at the time of notice.
- Prior three-month sales: The filing discloses six prior sales by Soleil Boughton totaling 45,189 shares with combined gross proceeds of $1,260,593.38 between August 19, 2026, and October 28, 2026.
Boughton's Proposed Class A Share Sale and Recent Trading History at Hims & Hers
According to the Form 144 filed with the U.S. Securities and Exchange Commission on November 17, 2026, Soleil Boughton, identified as an officer of Hims & Hers Health, Inc. (NYSE:HIMS), proposes to sell 3,458 Class A shares through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The filing reports an aggregate market value of $64,076.74 for the proposed sale. The shares were acquired on November 15, 2026, via restricted stock vesting from the issuer, with the nature of payment listed as compensation.
The filing discloses that Boughton adopted a written trading plan under Rule 10b5-1 on May 21, 2026. Pursuant to that plan, the filing records six Class A share sales in the three months preceding this notice: 25,111 shares sold on August 19, 2026, for gross proceeds of $691,808.05; 3,458 shares on September 2, 2026, for $97,965.14; 6,236 shares on September 16, 2026, for $173,734.96; 3,461 shares on September 30, 2026, for $100,957.37; 3,461 shares on October 14, 2026, for $100,576.66; and 3,462 shares on October 28, 2026, for $95,551.20.
The notice was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Soleil Boughton. The issuer's address is listed as 2269 Chestnut Street, #523, San Francisco, California 94123, with SEC File Number 001-38986.
What Was Disclosed
Soleil Boughton, an officer of Hims & Hers Health, Inc., filed a Form 144 on November 17, 2026, proposing to sell 3,458 Class A shares acquired through restricted stock vesting, with an aggregate market value of $64,076.74, under an existing Rule 10b5-1 plan.




Please wait processing your request...